Posts
November 04 2013
Staffing 360 Solutions, Inc. consummated and closed the acquisition of 100% of the issued and outstanding stock of Control Solutions International, Inc., a Florida corporation pursuant to a Stock Purchase Agreement dated August 14, 2013 by and among Staffing 360 Solutions, NewCSI, Inc., a Delaware corporation, and the shareholders of NCSI, for an aggregate purchase price of $530,300.93, consisting of cash and stock. EG&S acted as counsel to Staffing 360 Solutions, Inc.
October 31 2013
MELA Sciences, Inc. announced the closing of their Registered Direct offering in the amount of $6,000,000. EG&S acted as counsel to the Placement Agent.
October 24 2013
DARA BioSciences, Inc. announced the closing of their Registered Direct offering in the amount of $2,550,000. EG&S acted as counsel to the Placement Agent.
October 23 2013
Uranium Energy Corp. announced the closing of their Registered Direct offering in the amount of $7,100,003. EG&S acted as counsel to the Placement Agent.
October 22 2013
CorMedix Inc. announced the closing of their Registered Direct offering in the amount of $1,500,000. EG&S acted as counsel to the Investor.
October 18 2013
Aplifi, Inc., a leading provider of products that streamline the selling and maintenance of insurance products, was sold to Internet Pipeline, Inc. a provider of software tools to the insurance industry. Aplifi was a portfolio company of Bluff Point Associates Corp. EG&S acted as counsel to Aplifi and its shareholders.
October 17 2013
Douglas S. Ellenoff, a member of the Firm, was invited by The University of California, Berkeley, to participate in an international academic conference on crowdfunding titled "Crowdfunding; Setting the Research Agenda." UC researchers are interested in crowdfunding — particularly in the wake of the federal Jumpstart Our Business Start-ups Act, which relaxed some rules on how companies can ask for equity investments. Richard Swart, who leads crowdfunding research at Cal’s Fung Institute for Engineering Leadership, which is hosting the symposium, said part of the focus on the conference will be on “mechanisms to protect new investors.”
October 16 2013
Rexahn Pharmaceuticals, Inc. announced the closing of their Registered Direct offering in the amount of $5,300,000. EG&S acted as counsel to the Placement Agent.